Contineum Therapeutics, Inc. (CTNM)
8.28
-0.07
(-0.84%)
USD |
NASDAQ |
Oct 22, 09:52
Contineum Therapeutics Price to Book Value : 1.300 for Oct. 22, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 21, 2026 | 1.310 |
| October 20, 2026 | 1.328 |
| October 19, 2026 | 1.168 |
| October 16, 2026 | 1.111 |
| October 15, 2026 | 1.240 |
| October 14, 2026 | 1.278 |
| October 13, 2026 | 1.322 |
| October 12, 2026 | 1.344 |
| October 09, 2026 | 2.100 |
| October 08, 2026 | 2.068 |
| October 07, 2026 | 1.998 |
| October 06, 2026 | 1.985 |
| October 05, 2026 | 1.996 |
| October 02, 2026 | 2.059 |
| October 01, 2026 | 2.039 |
| September 30, 2026 | 2.106 |
| September 29, 2026 | 1.805 |
| September 28, 2026 | 1.998 |
| September 25, 2026 | 1.971 |
| September 24, 2026 | 1.960 |
| September 23, 2026 | 1.963 |
| September 22, 2026 | 2.103 |
| September 21, 2026 | 2.127 |
| September 18, 2026 | 2.124 |
| September 17, 2026 | 2.073 |
| Date | Value |
|---|---|
| September 16, 2026 | 2.160 |
| September 15, 2026 | 2.169 |
| September 14, 2026 | 2.326 |
| September 11, 2026 | 2.326 |
| September 10, 2026 | 2.301 |
| September 09, 2026 | 2.376 |
| September 08, 2026 | 2.502 |
| September 04, 2026 | 2.621 |
| September 03, 2026 | 2.758 |
| September 02, 2026 | 2.706 |
| September 01, 2026 | 2.597 |
| August 31, 2026 | 2.549 |
| August 28, 2026 | 2.676 |
| August 27, 2026 | 2.707 |
| August 26, 2026 | 2.671 |
| August 25, 2026 | 2.676 |
| August 24, 2026 | 2.61 |
| August 21, 2026 | 2.698 |
| August 20, 2026 | 2.514 |
| August 19, 2026 | 2.514 |
| August 18, 2026 | 2.276 |
| August 17, 2026 | 2.280 |
| August 14, 2026 | 2.227 |
| August 13, 2026 | 2.401 |
| August 12, 2026 | 2.351 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 12.68 |
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | 0.8868 |
| Fulcrum Therapeutics, Inc. | 0.9110 |
| Definium Therapeutics, Inc. | 5.255 |
Price to Book Value Related Metrics
| Price | 8.28 |
| Earnings Yield | -20.99% |
| Market Cap | 311.44M |